Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

OVERLAP
37%
OVERLAP
BY WEIGHT
13
# OF OVERLAPPING
HOLDINGS
FTXH
49
HOLDINGS
27%
ALSO IN PPH
PPH
26
HOLDINGS
57%
ALSO IN FTXH
SECTOR DRIFT (FTXH minus PPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in FTXH |
Weight in PPH |
Overlap | |
---|---|---|---|---|
JOHNSON & JOHNSON | 8.0% | 11.6% | 8.0% | |
MERCK & CO. INC. | 6.7% | 6.0% | 6.0% | |
ABBVIE INC | 7.8% | 5.2% | 5.2% | |
PFIZER INC | 6.7% | 4.5% | 4.5% | |
BRISTOL-MYERS SQUIBB CO | 5.8% | 4.2% | 4.2% |
FTXH Overweight Relative to PPH
UNITED THERAPEUTICS CORP | 4.7% | |
BIOGEN IDEC INC | 3.8% | |
GILEAD SCIENCES INC | 3.7% | |
AMGEN INC | 3.3% | |
VIATRIS, INC. | 3.3% | |
REGENERON PHARMACEUTICALS | 3.0% | |
MEDPACE HOLDINGS, INC. | 2.8% | |
JAZZ PHARMACEUTICALS PLC | 2.7% | |
ABBVIE INC | 2.6% | |
ELANCO ANIMAL HEALTH, INC. | 2.4% |
FTXH Underweight Relative to PPH
ELI LILLY & CO | -14.7% | |
NOVARTIS AG-ADR | -7.7% | |
NOVO-NORDISK A/S-SPONS ADR | -5.9% | |
ASTRAZENECA PLC-SPONS ADR | -4.9% | |
MCKESSON CORP | -4.5% | |
GLAXOSMITHKLINE PLC-SPON ADR | -4.5% | |
SANOFI-AVENTIS-ADR | -4.3% | |
CENCORA INC | -3.9% | |
JOHNSON & JOHNSON | -3.5% | |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | -2.9% |